期刊文献+

冠状动脉血流缓慢的危险因素分析 被引量:1

Analysis of Risk Factors in Native Slow Coronary Flow
原文传递
导出
摘要 探讨冠状动脉血流缓慢(Slow coronary flow,SCF)的临床特点、实验室检查、冠状动脉造影等特点,寻找SCF发生的影响因素。方法:通过TIMI血流帧计数法(Thrombolysis in myocardial infarction frame count,TFC)判断血流速度,入选2003年1月至2011年12月因胸痛等心肌缺血症状于我院心导管室行冠状动脉造影(Coronary artery angiography,CAG)的SCF患者376例,对照组为同期行CAG证实无冠脉显著狭窄且血流正常的患者共300例。记录临床资料,实验室指标及血流速度。结果:慢血流组年龄低于对照组[(57.9±10.1)岁比(61.0±9.4)岁,p=0.006],男性比例和吸烟史均高于对照组(分别为76.9%比42.0%,p<0.001和43.6%比24.0%,p<0.001)。慢血流组患者尿酸和甘油三酯升高,高密度脂蛋白胆固醇(HDL-C)和载脂蛋白A1(Apo-A1)明显低于对照组,分别为:尿酸:(364±90)μmol/L VS.(327±92)μmol/L,p<0.001;甘油三酯:(1.86±1.14)mmol/L VS.(1.64±0.91)mmol/L,p=0.007;HDL-C:(1.10±0.25)mmol/L VS.(1.22±0.36)mmol/L,p<0.001;和Apo-A1:(1.12±0.21)g/L VS.(1.29±0.26)g/L,p<0.001。多因素Logistic回归分析显示性别、甘油三酯、HDL-C和Apo-A1是预测慢血流发生的独立危险因素,其ORadj值依次为2.966(95%CI:1.891-4.654,p<0.001),1.395(95%CI:1.139-1.707,p=0.001),11.178(95%CI:3.896-32.070,p<0.001)和0.010(95%CI:0.003-0.037,p<0.001)。结论:性别、甘油三酯、HDL-C和Apo-A1是预测慢血流发生的独立危险因素。 Objective To analyze the clinical, laboratory and angiographic characteristics of patients with slow coronary flow (SCF), and to explore its influencing factors. Method: In this retrospective study, blood velocity was calculated with the method of Thrombolysis in myocardial infarction frame count (TFC). From January 2003 to December 2011,376 SCF patients and 300 control patients, who performed coronary artery angiography (CAG) in our DSA room, were enrolled in the study. CAG of SCF patients showed no more than 40% stenosis and delayed contrast occupation. Control subjects performed normal coronary artery and flow velocity. The clinical and laboratory data were obtained from medical records at admission, and blood velocity of each coronary artery was calculated according to TFC. Result: Compared to control subjects, SCF patients were younger [(57.9±10.1) years old VS. (61.0±9.4) years old, p=0.006], more men and smokers (male: 76.9% VS. 42.0%, p〈0.001; smokers: 43.6% VS. 24.0%, p〈0.001), high level of uric acid and triglyceride (TG), low level of high density lipoprotein cholesterol (HDL-C), and apoliporotein Al (Apo-Al) [uric acid: (364±90)μmol/L VS. (327±92)μmol/L, p〈0.001; TG: (1.86±1.14)mmol/L VS. (1.64±0.91)mmol/L, p=0.007; HDL-C: (1.10±0.25) mmol/L VS. (1.22±0.36) mmol/L, p〈0.001; and Apo-A 1 (1.12±0.21)g/L VS. (1.29±0.26)g/L, p〈0.001 ]. After adjustment for confounding factors in logistic analysis, the independent predictors for SCF were gender, TG, HDL-C, and Apo-Al, respectively ORadj=2.966 (95%Ci: 1.891- 4.654, p〈0.001), 1.395 (95%CI: 1.139-1.707, p=0.001), 11.178 (95%CI: 3.896-32.070, p〈0.001),0.010 (95% CI: 0.003-0.037, p〈0.001). Conclusion Gender, TG, HDL-C, and Apo-Al were independent predictors of native SCF.
出处 《中国分子心脏病学杂志》 CAS 2013年第5期673-676,共4页 Molecular Cardiology of China
关键词 冠心病 血流缓慢 危险因素 Coronary Artery Disease Slow Coronary Flow Risk Factors
  • 相关文献

参考文献2

二级参考文献20

  • 1Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow vdocity of dye in coronary arteries-.a new angiographic finding. Am Heart J, 1972,84:66-71.
  • 2Mosseri M, Yarom R, Cotsman MS, et al. Histologic evidence for small-vessel coronary artery disease in patients with angina peetoris and patent large coronary arteries. Circulation,1986,74:964-972.
  • 3Goel PK, Gupta SK, Agarwal A, et al. Slow coronary flow: a distinct angiographic subgroup in syndrome Ⅹ. Angiology,2001, 52:507-514.
  • 4Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation, 1996,93:879-888.
  • 5Kapoor A, Goel PK, Gupta S. Slow coronary flow - - a cause for angina with ST segment elevation and normal coronary arteries. A case report. Int J Cardiol, 1998,67:257-261.
  • 6Cutri N, Kucia AM, Beltrame JF, Continuous ST/T wave monitoring during an acute coronary syndrome presentation in patients with the coronary slow flow phenomenon (CSFP). Heart Lung Cite ,2008,17 :$95-$95.
  • 7Przybojewski JZ, Becker PH. Angina pectoris and acute myocardial infarction due to " slow-flow phenomenon " in nonatherosclerotie coronary arteries: a case report. Angiology, 1986,37:751-761.
  • 8Celik T, Iyisoy A, Kursaklioglu H, et al. ST elevation during treadmill exercise test in a young patient with slow coronary flow: a ease report and review of literature. Int J Cardiol, 2006,112 : E1- E4.
  • 9Demirkol MO, Yaymaci B, Muflu B. Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow. Coron Artery Dis ,2002,13:223-229.
  • 10Mangieri E, Tanzilli G, De Vincentis G, et al. Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med ( Hagerstown ), 2006,7 : 322- 327.

共引文献31

同被引文献18

  • 1Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectorisand slow flow velocity of dye in coronary arteries--a newangiographic finding. Am Heart J, 1972, 84(1):66-71.
  • 2Fragasso G, Chierchia SL, Arioli F, et al. Coronary slow-flowcausing transient myocardial hypoperfusion in patients with cardiacsyndrome X: long-term clinical and functional prognosis. Int JCardiol, 2009, 137(2):137-144.
  • 3Sezgin AT, Barutcu I, Sezgin N, et al. Contribution of plasma lipiddisturbances to vascular endothelial function in patients with slowcoronary flow. Angiology, 2006,57(6):694-701.
  • 4ICopetz V,Kennedy J,Heresztyn T, et al. Endothelial function,oxidative stress and inflammatory studies in chronic coronary slowflow phenomenon patients. Cardiology, 2012, 121(3):197-203.
  • 5Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: aquantitative method of assessing coronary artery flow. Circulation,1996, 93(5):879-888.
  • 6Sezgin AT, Sigirci A, Barutcu I,et al. Vascular endothelial functionin patients with slow coronary flow. Coron Artery Dis, 2003,14(2):155-161.
  • 7Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronaryflow: clinical and histopathoiogical features in patients withotherwise normal epicardial coronary arteries. Cathet CardiovascDiagn, 1996,37(4):375-381.
  • 8Tanriverdi H, Evrengul H, Kuru 0,et al. Cigarette smoking inducedoxidative stress may impair endothelial function and coronary bloodflow in angiographically normal coronary arteries. Circ J, 2006,70(5):593-599.
  • 9Yucel H, Ozaydin M, Dogan A, et al. Evaluation of plasmaoxidative status in patients with slow coronary flow. Kardiol Pol,2013,71(6):588-594.
  • 10Bilgi M, Gullu H,Kozanoglu 1,et al. Evaluation of blood rheologyin patients with coronary slow flow or non-obstructive coronaryartery disease. Clin Hemorheol Microcirc, 2013,53(4):317-326.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部